This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia, Molecular Cancer Therapeutics, February 2018, American Association for Cancer Research (AACR),
DOI: 10.1158/1535-7163.mct-17-0530.
You can read the full text:
The following have contributed to this page
